AAAAAA
Results:
1-16
|
Results: 16
Authors:
HAJEK R
ADAM Z
KRIVANOVA A
DOUBEK M
KORISTEK Z
VORLICEK J
Citation: R. Hajek et al., CURRENT ROLE OF IMMUNOTHERAPY IN MULTIPLE-MYELOMA, Acta medica austriaca, 25(3), 1998, pp. 79-85
Authors:
HAJEK R
VORLICEK J
ADLER J
VINKLARKOVA J
JANOVSKA E
KORISTEK Z
BOURKOVA L
DOUBEK M
KLABUSAY M
MAYER J
Citation: R. Hajek et al., EFFECT OF 24-HOURS CULTURE WITH INTERLEUKIN-2 ON PROGENITOR CELLS IN PERIPHERAL-BLOOD STEM-CELLS FROM PATIENTS WITH MULTIPLE-MYELOMA, Experimental hematology, 26(8), 1998, pp. 339-339
Authors:
ADAM Z
HAJEK R
SCUDLA Z
KUCA B
KOZA V
DRBAL J
INDRAK K
CAHOVA S
GUMULEC J
JANUSKA J
LEHANKA F
PRASKAC P
REZEK Z
VEPREK L
KREJCI M
BACOVSKY J
FRANKOVA H
SVOJGROVA M
PAPAJIK T
MARESCHOVA I
MAYER J
VORLICEK J
Citation: Z. Adam et al., THERAPY OF MULTIPLE-MYELOMA WITH HIGH-DOSE MELPHALAN AND PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT - FOLLOWED MAINTENANCE THERAPY WITH INTERFERON-ALPHA-2B (IFN) MONOTHERAPY OR SEQUENTIAL MAINTENANCE THERAPY IFN AND DEXAMETHASONE (DEX) - REPORT FROM ONGOING TRIAL 4W OF CZECH MYELOMA GROUP, Bone marrow transplantation, 21, 1998, pp. 740-740
Authors:
HAJEK R
Citation: R. Hajek, MALE FANTASIES - MALE IDENTITY AND THE CO LLECTIVE UNCONSCIOUS, Analytische Psychologie, 27(4), 1997, pp. 278-296
Authors:
HAJEK R
ADAM Z
VASOVA I
KRAL Z
Citation: R. Hajek et al., EVOLUTION OF MULTIPLE-MYELOMA TREATMENT FROM MELPHALAN MONOTHERAPY TOBONE-MARROW TRANSPLANTATION, Acta medica austriaca, 23(3), 1996, pp. 85-91
Authors:
HAJEK R
VASOVA I
ADAM Z
MAYER J
Citation: R. Hajek et al., NEW APPROACHES TO MANAGEMENT OF MULTIPLE-MYELOMA, Acta medica austriaca, 23(3), 1996, pp. 91-98
Authors:
HAJEK R
Citation: R. Hajek, SEMINARS - DREAM ANALYSIS - GERMAN - JUNG ,CG, Analytische Psychologie, 27(1), 1996, pp. 51-53
Authors:
HAJEK R
VORLICEK J
SLAVIK M
Citation: R. Hajek et al., PACLITAXEL (TAXOL(R)) - A REVIEW OF ITS ANTITUMOR-ACTIVITY IN CLINICAL-STUDIES - MINIREVIEW, Neoplasma, 43(3), 1996, pp. 141-154
Authors:
MAYER J
HAJEK R
VORLICEK J
TOMISKA M
Citation: J. Mayer et al., SEPSIS AND SEPTIC SHOCK .1. DEFINITIONS AND PATHOPHYSIOLOGY, Supportive care in cancer, 3(2), 1995, pp. 106-110
Authors:
MAYER J
HAJEK R
VORLICEK J
TOMISKA M
Citation: J. Mayer et al., SEPSIS AND SEPTIC SHOCK .2. TREATMENT, Supportive care in cancer, 3(2), 1995, pp. 111-119
Authors:
ADAM Z
KRAHULOVA M
SPELDA S
VORLICEK J
HEJLOVA N
HAJEK R
TOMISKA M
Citation: Z. Adam et al., THERAPY OF ANEMIA IN PATIENTS WITH MULTIPLE-MYELOMA, Acta medica austriaca, 22(4), 1995, pp. 59-64
Authors:
BREITENEDER H
SCHEINER O
HAJEK R
HULLA W
HUTTINGER R
FISCHER G
KRAFT D
EBNER C
Citation: H. Breiteneder et al., DIVERSITY OF TCRAV AND TCRBV SEQUENCES USED BY HUMAN T-CELL CLONES SPECIFIC FOR A MINIMAL EPITOPE OF BET-V-1, THE MAJOR BIRCH POLLEN ALLERGEN, Immunogenetics, 42(1), 1995, pp. 53-58
Authors:
HEITGER A
NEU N
STUGER U
HAJEK R
NIEDERWIESER D
FINK FM
Citation: A. Heitger et al., ABERRANT CD45 ISOTYPE EXPRESSION ON T-CELLS AFTER THYMECTOMY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2851-2851
Authors:
ADAM Z
VORLICEK J
KRALOVA E
HAJEK R
HEJLOVA N
Citation: Z. Adam et al., LACK OF EFFECT OF INTERFERON-ALPHA THERAP Y IN A PATIENT WITH PRIMARYAMYLOIDOSIS, Acta medica austriaca, 21(5), 1994, pp. 137-139
Authors:
ADAM Z
ELBL L
VORLICEK J
HAJEK R
HAJEK D
HEJLOVA N
KRALOVA E
NOVOTNA H
Citation: Z. Adam et al., TREATMENT OF REFRACTORY MULTIPLE-MYELOMA WITH VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, AND WITH REPEATED APPLICATION OF CYCLOPHOSPHAMIDE (C-VAD), Acta medica austriaca, 21(4), 1994, pp. 111-115
Authors:
HAJEK R
Citation: R. Hajek, ANALYTICAL PSYCHOLOGY BETWEEN IMAGINATION AND EXPERIENCE - CONSIDERATIONS ON THE PERCEPTION OF A DREAM, Analytische Psychologie, 25(2), 1994, pp. 83-99
Risultati:
1-16
|